QFITLIA FITUSIRAN Trademark
Trademark Overview
On Friday, March 17, 2023, a trademark application was filed for QFITLIA FITUSIRAN with the United States Patent and Trademark Office. The USPTO has given the QFITLIA FITUSIRAN trademark a serial number of 97844925. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, April 11, 2023. This trademark is owned by Genzyme Corporation. The QFITLIA FITUSIRAN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders, pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections; pharmaceutical preparations for the treatment of lysosomal storage diseases
General Information
| Serial Number | 97844925 |
| Word Mark | QFITLIA FITUSIRAN |
| Filing Date | Friday, March 17, 2023 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Tuesday, April 11, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the stylized wording 'QFITLIA FITUSIRAN.' QFITLIA appears in blue with a yellow circle at the top of the tail of the 'Q,' a yellow circle above the first letter 'I,' and a row of stylized yellow circles over the letters 'IA.' FITUSIRAN appears underneath the letters 'ITLIA' in grey. |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders, pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections; pharmaceutical preparations for the treatment of lysosomal storage diseases |
| Indication of Colors claimed | The color(s) blue, yellow, and grey is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 10, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Genzyme Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02141 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 11, 2023 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
| Monday, March 27, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, April 11, 2023 | ABANDONMENT - EXPRESS MAILED |
| Thursday, April 6, 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Tuesday, April 11, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, April 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 21, 2023 | NEW APPLICATION ENTERED |
